Development of a cost-effective 'duplexed' real-time PCR assay for minimal residual disease monitoring of chronic myeloid leukemia using locked nucleic acid probes.

about

Development of a cost-effective 'duplexed' real-time PCR assay for minimal residual disease monitoring of chronic myeloid leukemia using locked nucleic acid probes.

Item

http://www.wikidata.org/entity/Q54148021

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Development of a cost-effectiv ...... ng locked nucleic acid probes.

@en

Development of a cost-effectiv ...... ng locked nucleic acid probes.

@nl

type

Item

label

Development of a cost-effectiv ...... ng locked nucleic acid probes.

@en

Development of a cost-effectiv ...... ng locked nucleic acid probes.

@nl

prefLabel

Development of a cost-effectiv ...... ng locked nucleic acid probes.

@en

Development of a cost-effectiv ...... ng locked nucleic acid probes.

@nl

P1476

Development of a cost-effectiv ...... ing locked nucleic acid probes

@en

P2093

H Doshi

http://www.w3.org/2001/XMLSchema#string

P G Subramanian

http://www.w3.org/2001/XMLSchema#string

P Tembhare

http://www.w3.org/2001/XMLSchema#string

R Mascerhenas

http://www.w3.org/2001/XMLSchema#string

S Chaudhary

http://www.w3.org/2001/XMLSchema#string

S Gujral

http://www.w3.org/2001/XMLSchema#string

S Joshi

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic myeloid leukemia data from India

Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program.

Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program.

Selection of fluorophore and quencher pairs for fluorescent nucleic acid hybridization probes.

European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013.

Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA.

A real-time polymerase chain reaction assay for rapid, sensitive, and specific quantification of the JAK2V617F mutation using a locked nucleic acid-modified oligonucleotide.

Guidelines for the measurement of BCR-ABL1 transcripts in chronic myeloid leukaemia.

Fast-mode duplex qPCR for BCR-ABL1 molecular monitoring: innovation, automation, and harmonization.

Assessment of BCR-ABL1 transcript levels at 3 months is the only requirement for predicting outcome for patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors.

P304

e102-e106

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/IJLH.12541

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nikhil Patkar

P577

2016-07-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27461906

http://www.w3.org/2001/XMLSchema#string

P921

chronic myeloid leukemia